M&A activity sparks investment opportunities in pharmaceuticals: Hot picks
There’s been an uptick in merger and acquisition activity within the biopharmaceuticals industry and one financial expert says several companies are well positioned to benefit from future anticipated deals. In an interview with BNN Bloomberg’s Amber Kanwa...